![Jörg Hager](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Dr Hager joined Integragen as Founder and Chief Scientific Officer in 2001.
Most recently, he was head of genotyping at the National Genotyping Center (France), joining in 1998.
In 1995, he moved to the Institut Pasteur in Lille (France) where he was involved in establishing the new department for the study of multi-factorial diseases of the CNRS.
There he headed the "Genetics of Obesity" research team that led to the identification of a major obesity susceptibility locus on chromosome 10 in 1997.
Dr Hager has over thirty (30) publications and five (5) patents, most of which are associated with the genetics of metabolic disorders, and Integragen's GenomeHIP technology.
Former positions of Jörg Hager
| Companies | Position | End |
|---|---|---|
| INTEGRAGEN | Founder | 31/12/2008 |
Training of Jörg Hager
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
IntegraGen SA
 IntegraGen SA Medical/Nursing ServicesHealth Services Develops cutting edge genome analysis products | Health Services |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jörg Hager
